When Screening Guidelines Shift: Impacts on Healthcare Access & Use

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs Publishing's Jeff Byers welcomes Duke University School of Medicine's Mike Pignone to the pod to explore the new cholesterol screening guidelines, how evolving screening and treatment guidelines (including colon cancer and breast cancer screening guidelines) influence care, and the broader cost implications for the health system.

Join Health Affairs Publishing on May 13 for an exclusive Insider virtual event exploring individual coverage health reimbursement arrangements (ICHRAs) with Urban Institute’s Jason Levitis.

Related Articles:

• Generic cholesterol drugs save Medicare billions of dollars, study finds (UT Southwestern Medical Center)
• Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare Beneficiaries (JAMA)
• A cholesterol test you've never heard of is now recommended to prevent heart disease (NPR)
• ACC/American Heart Association Issue Updated Guideline for Managing Lipids, Cholesterol (American Heart Association)

Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Subscribe to Semafor Healthcare for free.